Under the terms of the agreement, Renovaro and Amsterdam UMC will work together to refine and improve predictive performance, ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients.

In a groundbreaking discovery, scientists from the University of Cambridge have found that aspirin could play a key role in ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both ...

The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS -mutated recurrent ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

The FDA has granted accelerated approval to Avmapki (avutometinib) plus Fakzynja (defactinib) for the treatment of KRAS-mutated, recurrent low-grade serous ovarian cancer.

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge difference in treating the disease. Breast cancer is one of the few ...

One of the children was undergoing cancer treatment and one of the mothers is pregnant. Both families had lived in the country for years and had ties to their communities, according to the ...

A platelet count measures the average platelet level in a person’s blood. High or low platelet levels can increase the risk of clotting or excessive bleeding. Platelets, also called thrombocytes ...